858127C

17:1 Lyso PG

1-(10Z-heptadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

• Synonym(e): 1-heptadecenoyl-2-hydroxy-sn-glycero-3-phospho-(1′racglycerol) (sodium salt); PG(17:1(10Z)/0:0); 110712
• Empirische Formel (Hill-System): C₂₃H₄₄NaO₉P
• CAS-Nummer: 1246298-11-2
• Molekulargewicht: 518.55
• UNSPSC-Code: 51191904
• NACRES: NA.25

Eigenschaften

• Assay: >99% (LPG; may contain up to 10% of the 2-LPG isomer, TLC)
• Form: liquid
• Verpackung: pkg of 1 × 1 mL (858127C-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 858127C
• Konzentration: 5 mg/mL (858127C-5mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

Lyso-phospholipids are non bilayer-forming lipids, which are produced in γ-proteobacteria. They are present in normal bacterial membranes.

Anwendung

17:1 Lyso PG has been used as a standard for lipid profiling of rat peritoneal surface layers in liquid chromatography-mass spectrometry (LC-MS) method .

Biochem./physiol. Wirkung

Lyso phosphoglycerol (Lyso PG) and acyl-CoA facilitates the synthesis of phosphoglycerol using lysophosphatidylglycerol acyltransferase 1 (LPGAT1). Lysophospholipids exhibits detergent- like physical property.

Verpackung

5 mL Clear Glass Sealed Ampule (858127C-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• P-Sätze: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system, Liver,Kidney
• WGK: WGK 3